Recital 14, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

As the Authority needs additional time to reach a conclusion on the risk assessment for the active substance phosphane requiring, where appropriate, a consultation of experts, the duration of the extension of the approval period for this active substance should be set at 23 months and 2 weeks.